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Abstract Ultraviolet-B irradiation of human dermal fibroblasts
has earlier been shown to induce matrix-degrading metallopro-
teinases, thus driving connective tissue degradation in photoaging
and photocarcinogenesis. Herein, we report that Ultraviolet-B
irradiation led to a dramatic increase in specific mRNA and
protein levels of interstitial collagenase, stromelysin and inter-
leukin-6. By contrast, the major tissue inhibitor of matrix-
degrading metalloproteinases, TIMP-1, was unaffected. Mono-
specific neutralizing antibodies directed against human inter-
leukin-6 significantly reduced the interstitial collagenase and
stromelysin-1 protein levels. Taken together, our data provide the
first evidence that Ultraviolet-B induction of interstitial collage-
nase and stromelysin-1 occurs via the synthesis and release of
interleukin-6. Hence, this newly identified autocrine mechanism
may contribute to dermal photodamage.
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1. Introduction
The increase in ultraviolet (UV)-B irradiation (280^320 nm)
on earth due to stratospheric ozone depletion represents a
major environmental threat to the skin, substantially increas-
ing its risk of photodamage with long-term consequences as
photoaging and photocarcinogenesis [1^3]. Besides the gener-
ation of reactive oxygen species (ROS) [4,5] and the formation
of potentially mutagenic DNA damage in skin cells [3,6,7],
UVB irradiation induces changes in the expression of many
genes [8^10] involved in signal transduction pathways, the cell
cycle control, tumor promotion and progression. UVB-induc-
ible genes comprise several proteinases, among them matrix-
degrading metalloproteinases (MMP) [11,12] which have been
linked to tumor invasion, metastasis [13] and cutaneous pho-
toaging [3,12,14]. Furthermore, UVB irradiation triggers the
release of various cytokines from human keratinocytes in vivo
and in vitro, among them interleukin-1 (IL-1), IL-6 and tumor
necrosis factor alpha (TNFK) [15^17].
In dermal ¢broblasts, evidence was provided for an UVA-
induced cytokine network consisting of IL-1K, IL-1L and IL-6
which, via inter-related autocrine loops, induced interstitial
collagenase (MMP-1) and, thus, may contribute to the loss
of dermal interstitial collagen, a hallmark in photoaging
[3,18].
Even though UVA irradiation penetrates much deeper into
the dermal connective tissue, UVB irradiation has been shown
to reach at least the upper layers of the dermis [19]. In this
study, we, therefore, addressed the questions whether (1) the
cytokines IL-1K, IL-1L and IL-6 can be induced in human
dermal ¢broblasts by UVB irradiation and, if so, whether
(2) the identi¢ed cytokine(s) are subsequently involved in
the UVB-mediated up-regulation of ¢broblast-derived
MMP-1 and/or stromelysin-1 (MMP-3).
Our data provide several lines of direct evidence that UVB
irradiation signi¢cantly induced IL-6 which, via an autocrine
mechanism, regulates the increase in the steady-state protein
levels of MMP-1 and MMP-3, most likely contributing to the
loss of interstitial collagen and other structural proteins in
dermal connective tissue. Interestingly, in contrast to the au-
tocrine role of IL-1K and IL-1L in the UVA induction of
MMP, IL-1K and IL-1L were only marginally induced after
UVB irradiation, while, similar to the UVA response, IL-6
protein levels signi¢cantly increased upon UVB irradiation.
These data suggest that UVB and UVA activate, at least in
part, distinct pathways leading ¢nally to the induction of
MMPs and tissue degradation.
2. Materials and methods
2.1. Reagents
Cell culture medium and Trizol reagent were purchased from Life
Technologies (Eggenstein, Germany) and fetal calf serum (FCS) from
Biochrom (Berlin, Germany). All chemical and biochemicals were
obtained from Sigma (Deisenhofen, Germany) unless otherwise indi-
cated. The human IL-6 mRNA assay (Xplore mRNA Quanti¢cation
Systems) was purchased from Endogen (Woburn, MA, USA). Goat
anti-human IL-6 neutralizing antibody and normal goat IgG isotype
control were from R and D Systems (Wiesbaden, Germany). MMP-1,
MMP-3 and TIMP-1 ELISA kits (Biotrak) were obtained from Amer-
sham (Braunschweig, Germany). The IL-1, IL-6 and TNFK ELISA
components (CLB, Amsterdam, The Netherlands) were purchased
from Hiss Diag-nostics (Freiburg, Germany). Protein G-agarose was
from Boehringer (Mannheim, Germany).
2.2. Cell culture
Dermal foreskin ¢broblasts were established by outgrowth from
biopsies of healthy human donors [20] with an age of 3^6 years and
cultured in Dulbecco’s modi¢ed Eagle’s medium (DMEM) supple-
mented with glutamine (2 mM), penicillin (400 U/ml), streptomycin
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(50 mg/ml), 10% FCS and grown on plastic tissue culture dishes in a
humidi¢ed atmosphere of 5% CO2 and 95% air at 37‡C. Cells were
used at passages 5^15 corresponding to cumulative population dou-
bling levels 10^32 [21].
2.3. Light source and UV irradiation
A 1000 Watt (W) Xenon high pressure UV source was used in
conjunction with a monochromator with holographic grating (Dermo-
lum UMW, Fa. Muºller, Moosinning, Germany). For the experiments,
the total UVB spectrum (280^320 nm) was used. Fluence rates were
determined by an integrated thermopile. The £uence rates on the cell
surface were 0.34 mW/cm2 (3.4 W/m2) for the total UVB spectrum.
The resulting exposure time (t) (in s) was determined by the equation
t = dose (mJ/cm2)/£uence rate (mW/cm2). Thus, UVB irradiation at a
dose of 10 mJ/cm2 resulted in an exposure time of 29.4 s. To guar-
antee a constant intensity and spectral distribution, dosimetry and
spectroradiometric analyses were performed prior to experiments
with an OL-754 UV/visible light spectroradiometer (Optronic, Orlan-
do, FL, USA). Con£uent ¢broblast monolayer cultures were rinsed
twice with pre-warmed (37‡C) phosphate-bu¡ered saline (PBS) and
thereafter irradiated at a dose of 10 mJ/cm2 of the complete UVB
spectrum under a thin layer of pre-warmed PBS [22]. There was a
negligible loss in viability of cell populations compared to cells held
under similar conditions without irradiation [22]. Following UV irra-
diation, cells were washed with PBS and cultivated in DMEM without
FCS for various periods of time prior to the mRNA or protein quan-
ti¢cation.
2.4. Enzyme-linked immunoassay (ELISA)
Cytokine ELISAs were performed according to the manufacturer’s
protocols. Brie£y, 96 well immunoplates were coated overnight at
room temperature with the appropriate monoclonal anti-human cyto-
kine antibodies (1 Wg/ml, 100 Wl/well) in 0.1 M carbonate/bicarbonate
bu¡er (pH 9.5). After this and each subsequent step, plates were
washed four times with PBS containing 0.005% Tween 20. After
blocking the non-speci¢c binding, serial dilutions of cytokine stand-
ards or the supernatants to be tested (100 Wl/well) were incubated for
1 h at room temperature. Subsequently, plates were incubated at room
temperature with 100 Wl/well of the diluted biotinylated sheep anti-
human cytokine antibody (1:100) and horseradish peroxidase-conju-
gated streptavidin (1:10 000) for 1 h and 30 min, respectively. Finally,
100 Wl of 3,3P,5,5P tetramethylbenzidine (TMB) peroxidase substrate
solution (0.42 mM TMB/0.003% H2O2 in 0.11 M sodium acetate
bu¡er (pH 5.5)) was added to each well and the reaction was stopped
after 15 min by 100 Wl of 2 M sulfuric acid per well. Optical densities
were read at 450 nm using a microtiter plate reader. Concentrations of
di¡erent cytokines to be tested in the samples were determined against
standard curves using GraphPad software (San Diego, CA, USA).
The MMP-1, MMP-3 and TIMP-1 ELISAs were performed according
to the manufacturer’s protocols basically corresponding to the proce-
dure described above.
2.5. Isolation of total RNA and IL-6 mRNA quanti¢cation
Total RNA from ¢broblasts was prepared using the Trizol method
(Life Technologies). 0.5 Wg of total RNA per sample was used for the
IL-6 mRNA quanti¢cation assay according to the manufacturer’s
recommendations with minor modi¢cations. The principle of this as-
say is based on the fact that two target-speci¢c oligonucleotide probes
hybridize to a splice junction present in the IL-6 or other speci¢c
mRNA. The 3P-end of the so called invader probe overlaps the speci¢c
sequences to which hybridization of the signal probe occurs. The
cleavase VII enzyme recognizes and cleaves the 5P-end overlapping
signal fragment leading to a signi¢cant signal ampli¢cation. The in-
crease in the speci¢c signal probe fragments is due to the isothermal
reaction cycle (1 h) at a temperature (54‡C) near the melting temper-
ature of the signal probe. The accumulation of the signal fragments is
directly proportional to the number of target mRNA transcripts. The
accumulated signal probe fragments are subsequently captured on a
streptavidin-coated plate by a biotinylated capture oligo which forms
a primer-template substrate for DNA polymerase. DNA polymerase
subsequently extends the signal fragments with £uorescein-dUTP (F-
dUTP) (15 min, 37‡C). Thereafter, the plates were washed three times
and the F-dUTP was detected by an anti-£uorescein alkaline phos-
phatase-conjugated antibody. Here, 0.5 mM 4-nitrophenyl phosphate
in 10% diethanolamine (pH 9.8) was used as a substrate for phospha-
tase (30 min, 37‡C) and the yellow reaction product was measured at
405 nm. The precise number of IL-6 mRNA transcripts in the samples
was determined by comparing the signal generated by the samples to a
standard curve.
2.6. Neutralization studies
UVB irradiation of con£uent human dermal ¢broblasts at a dose of
10 mJ/cm2 was performed in PBS in the presence of di¡erent concen-
trations of neutralizing IL-6 antibodies (5 and 25 Wg/ml medium).
Subsequently, the PBS/antibody solution was removed and replaced
by cell culture medium supplemented with the neutralizing antibody
at the same concentrations. 24 h thereafter, the supernatants were
collected for determination of the MMP-1, MMP-3 and TIMP-1 pro-
tein levels. For control purposes, identical experiments were per-
formed in parallel using equal amounts of goat control IgG.
2.7. Immunoprecipitation
24 h after treatment or mock-treatment of UVB-irradiated ¢bro-
blasts with neutralizing IL-6 antibodies, the supernatants were col-
lected and incubated with 50 Wl/ml of the homogeneous protein G-
agarose suspension supernatant for 3 h at 4‡C on a rocking platform.
Thereafter, the antigen-antibody complexes bound to protein G were
removed by centrifugation at 12 000Ug for 30 s in a microfuge. Sub-
sequently, the IL-6 levels were determined in the supernatants as
mentioned above.
3. Results
3.1. Increase in MMP-1 and MMP-3 protein levels upon UVB
irradiation
Supernatants were collected from irradiated and mock-irra-
diated ¢broblasts at 0.5, 1, 2, 4, 8, 16 and 24 h following UVB
irradiation at a dose of 10 mJ/cm2 and subjected to ELISAs
for the determination of MMP-1, MMP-3 and TIMP-1 (Fig.
1). A low constitutive expression of MMP-1, MMP-3 and
TIMP-1 was measured in mock-irradiated cells. 16 and 24 h
following UVB irradiation, signi¢cant increases in accumu-
lated MMP-1 and MMP-3 protein levels were observed with
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Table 1
Time course analysis of the increase in IL-6, IL-1K and IL-1L protein levels after UVB irradiation (280^320 nm) of human dermal ¢broblasts
Time after irradiation (h) mean þ S.D. (pg/mg total protein)
IL-6 IL-1K IL-1L
Control (C) 3.9 þ 0.5 1.4 þ 0.3 0.8 þ 0.1
0.5 3.6 þ 0.6 1.8 þ 0.3 1.6 þ 0.4
1.0 4.1 þ 1.2 1.8 þ 0.5 1.0 þ 0.4
2.0 2.8 þ 1.2 1.5 þ 0.8 1.2 þ 0.2
4.0 37.7 þ 3.0 1.0 þ 0.2 0.9 þ 0.3
16.0 103.3 þ 11.6 2.6 þ 0.1 1.4 þ 0.3
24.0 131.9 þ 3.4 1.2 þ 0.4 1.3 þ 0.2
Con£uent ¢broblasts were irradiated at a dose of 10 mJ/cm2 UVB. Thereafter, supernatants were collected at di¡erent time points post-irradiation.
Quantitative analysis of speci¢c protein levels was performed by ELISA using corresponding standard curves. Three independent experiments were
performed. C, control (mock-irradiated cells) ; S.D., standard deviation; P6 0.0001 (ANOVA) compared to mock-irradiated cells.
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an 11- and 9-fold increase in MMP-1 and MMP-3 protein
levels compared to mock-irradiated ¢broblasts. By contrast,
TIMP-1 protein levels were una¡ected compared to the con-
trols. These ¢ndings corroborate and extend previous data
[11,22].
3.2. UVB irradiation results in an increase in the synthesis and
release of IL-6 in dermal ¢broblasts
To study the e¡ect of UVB irradiation on the protein levels
of speci¢c cytokines like IL-1K, IL-1L and IL-6, time course
experiments were performed (Table 1). A low constitutive
protein level of all tested cytokines was detected in the super-
natant of mock-irradiated cells. A signi¢cant increase in IL-6
levels was ¢rst observed at 4 h post-irradiation with a further
time-dependent increase. 24 hours after UVB irradiation, a
33-fold increase in IL-6 protein levels was determined com-
pared to that of mock-irradiated controls. By contrast, the IL-
1K and IL-1L protein levels were not signi¢cantly increased
upon UVB irradiation (Tab. 1). In order to further address
the question whether the release of IL-6 into the supernatant
was due to an increase in the IL-6 synthesis or rather resulted
from the release of pre-formed IL-6, the e¡ect of UVB irra-
diation on IL-6 mRNA levels was investigated (Fig. 2). For
this purpose, time course experiments were performed. Fol-
lowing UVB irradiation, IL-6 mRNA levels signi¢cantly in-
creased 2 h post-irradiation and peaked at 4 h post-irradiation
with a maximal 9.6-fold increase in IL-6 mRNA levels (Fig.
2). Thereafter, the mRNA levels decreased and reached a
similar level as the mock-irradiated cells 24 h post-irradiation.
The increase in IL-6 mRNA correlated with the increase in
IL-6 protein levels suggesting that the release of IL-6 was due
to de novo synthesis of IL-6. This was further supported by
the observation that in lysates of ¢broblasts no signi¢cant
amount of IL-6 was detected (data not shown).
3.3. Neutralizing antibodies against human IL-6 prevent the
UVB-mediated MMP-1 and MMP-3 induction
To establish whether the UVB-induced MMP-1 and MMP-
3 synthesis is regulated via an autocrine loop of IL-6, anti-
body neutralization experiments were performed. Interest-
ingly, UVB induction of MMP-1 and MMP-3 on the protein
level was almost completely suppressed by neutralizing anti-
bodies directed against IL-6 (Fig. 3). Neither lower concen-
trations of the neutralizing antibody against IL-6 (data not
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Fig. 2. Time-dependent induction of IL-6 transcription following
UVB irradiation. Con£uent ¢broblasts were UVB-irradiated at a
dose of 10 mJ/cm2. Total RNA was isolated from ¢broblasts at dif-
ferent time points post-irradiation and subjected to the mRNA
quanti¢cation assay. Quanti¢cation of speci¢c mRNA levels was
performed using de¢ned standard curves as described in Section 2.
The results are the mean þ S.D. of three independent experiments.
The inset shows the standard curve (r2 = 0.89) of the IL-6 mRNA
assay. C, control (mock-irradiated cells); S.D., standard deviation;
*P = 0.0019 (ANOVA) compared to controls.
Table 2
Modulation of IL-6 protein levels after UVB irradiation by neutralizing antibodies against human IL-6
UVB (+) UVB (q)
Anti-IL-6 (Wg/ml SN) 0 5 25 0
IL-6 (pg/mg total protein) 154.4 þ 13.1 2.9 þ 0.2 3.0 þ 0.2 2.8 þ 0.1
Con£uent ¢broblasts were UVB-irradiated, incubated with neutralizing antibodies against IL-6 and thereafter, the antigen/antibody complex was
removed by protein G agarose. The concentrations of IL-6 protein in the sample supernatants (SN) were determined against IL-6 standards
described in Section 2 and expressed as mean þ S.D. values of three independent experiments. UVB (+), UVB irradiation at a dose of 10 mJ/cm2 ;
UVB (q), mock-irradiated cells ; S.D., standard deviation.
Fig. 1. The time-dependent increase in MMP-1 and MMP-3 protein
levels following UVB irradiation. Con£uent ¢broblasts were irradi-
ated at a dose of 10 mJ/cm2 with the complete UVB spectrum.
Thereafter, supernatants were subjected to ELISAs at di¡erent
time points post-irradiation. The quantitative analysis of speci¢c
protein levels in the samples was determined using standard curves.
The results are the mean þ S.D. of three independent experiments.
C, control (mock-irradiated cells) ; S.D., standard deviation; *,
#P6 0.0001 (two-sided t test) compared to mock-irradiated cells.
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shown) nor the normal goat IgG at identical concentrations
(Fig. 3) exerted any e¡ect on MMP protein levels. Following
UVB irradiation, no signi¢cant change in TIMP-1 protein
levels was observed in the presence of neutralizing antibodies
against IL-6 or isotype control IgG.
3.4. Anti-human IL-6 reduces IL-6 levels in the supernatant of
UVB-irradiated cells
To address the question whether the reduction in MMP
protein levels depended on the formation of antigen(IL-6)-
antibody complexes and not on non-speci¢c e¡ects, superna-
tants of UVB-irradiated ¢broblasts were incubated with dif-
ferent concentrations of neutralizing antibodies. Finally, the
antigen/antibody complexes were removed and the superna-
tants tested for IL-6. Table 2 shows that the IL-6 protein
levels were dramatically reduced upon incubation with anti-
human IL-6 antibody compared to the only UVB-irradiated
controls. The IL-6 levels of UVB-irradiated ¢broblasts in the
presence of neutralizing antibodies were almost identical to
that of the mock-irradiated controls (Table 1). This ¢nding
suggests that the reduction in MMP-1 and MMP-3 protein
levels, in fact, depended on the inactivation of IL-6 by the
neutralizing antibody.
4. Discussion
In vivo and in vitro studies in human dermal ¢broblasts
have shown that the induction of MMP and distinct members
of the serine protease family play an important role in the
profound quantitative and qualitative alterations underlying
photodamage of the dermal connective tissue in photoaging
and photocarcinogenesis [3,23,24]. Several chemical and phys-
ical agents stimulate the synthesis and activation of the
MMPs, among them UVA and UVB radiation [3,11,12,
18,22,25]. Speci¢cally, MMP-1 and MMP-3, responsible for
the breakdown of dermal interstitial collagen and proteo-
glycans, were dose-dependently induced in vitro and in vivo
following UVA and UVB irradiation [11,12,18,22,25^27].
Apart from the potential clinical implication of these ¢nd-
ings [3,28,29], over the past years, many studies focused on
the complex regulatory molecular and cellular mechanisms
underlying UVA/B-mediated up-regulation of MMPs. Re-
cently, several components of the intracellular signal trans-
duction pathways as well as transcription factors have been
identi¢ed to be involved in the UVB-mediated induction of
MMPs [11,12,27]. Furthermore, UVB-generated ROS and
iron appear to be central factors in the up-regulation of
MMPs [12]. For UVA (340^400 nm)-dependent induction of
MMP-1, we previously provided evidence that a cytokine net-
work consisting of IL-1K, IL-1L and IL-6 induced MMP-1 via
inter-related autocrine loops [18,30]. We furthermore showed
that UVA generation of singlet oxygen and hydrogen perox-
ide preceded the synthesis and release of these cytokines
[3,31].
Although there is evidence that UVB irradiation contrib-
uted to the synthesis and release of cytokines like IL-1, IL-6
and TNFK in keratinocytes in vitro and in vivo [15,17,32],
only scant information exists regarding a potential e¡ect of
UVB irradiation on the cytokine stimulation in human dermal
¢broblasts. Here, we report a causal autocrine relationship
between UVB-mediated induction of the cytokine IL-6 and
the increase in MMP-1 and MMP-3 protein levels in human
dermal ¢broblasts in vitro. As to our data, IL-6 protein levels
accumulated up to 24 h post-irradiation, while IL-6 mRNA
levels peaked at 4 h and decreased thereafter. These ¢ndings
rule out that the UVB-induced increase in IL-6 expression is
only mediated by a post-transcriptional mechanism by the
increase in the stability of IL-6 transcripts as has previously
been postulated for human keratinocytes [33]. Furthermore,
our data are in line with previously published results. These
data showed that normal human fetal skin ¢broblasts re-
sponded to exogenously added IL-6 with an increase in the
synthesis of interstitial collagenase [34,35]. Furthermore, there
is evidence that human recombinant IL-6 concentrations in
the range of pg/ml led to a signi¢cant increase in the collage-
nase activity compared to mock-treated controls [36].
In contrast to UVA-irradiated ¢broblasts [18], IL-1K and
IL-1L protein levels were only marginally increased upon
UVB irradiation compared to the dramatic increase in IL-6
suggesting that IL-1 may not play an important role in the
UVB-dependent MMP-1 and MMP-3 induction. However,
exogeneously added IL-1K and IL-1L to cell cultures at
much higher concentrations (v100 pg/ml) as measured in
this study induced MMP-1 [37,38] and MMP-3 [38]. Our ¢nd-
ings are in line with previously published data showing that
during in£ammatory processes, mechanisms leading to the
synthesis and release of IL-6 are independent on the involve-
ment of IL-1 [39,40].
Taken together, these data contribute to a novel facet of the
previously published concept which postulates that UVB irra-
diation of the skin leads to a keratinocyte-dependent release
of growth factors and cytokines IL-1, IL-6 and TNFK which,
via paracrine mechanisms, modulate the connective tissue me-
tabolism of ¢broblasts [17,41,42]. Here, we add an independ-
ent autocrine mechanism.
The intermediate molecular steps from IL-6 release to
MMP-1 and MMP-3 induction after UVB irradiation are still
unclear and speculative. Even high concentrations of neutral-
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Fig. 3. IL-6 mediates the UVB induction of MMP-1 and MMP-3
via an autocrine mechanism. Con£uent ¢broblasts were UVB-irradi-
ated at a dose of 10 mJ/cm2. Supernatants from UVB-irradiated
and mock-irradiated ¢broblasts which had been incubated with dif-
ferent concentrations of anti-IL-6 and normal IgG were subjected to
ELISAs, 24 h post-irradiation. Quantitative analysis of speci¢c pro-
tein levels in de¢ned samples was performed using established stand-
ard curves. The results are the mean þ S.D. of three independent ex-
periments. C, control (mock-irradiated cells) ; S.D., standard
deviation; *, #P6 0.0001 (ANOVA) compared to only UVB-irradi-
ated cells.
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izing antibodies against IL-6 could not completely inhibit the
UVB induction of MMP-1 and MMP-3 indicating that IL-6
plays an important but not an exclusive role in the regulation
of UVB-induced MMPs. UV-induced DNA damage [8,41]
and reactive oxygen species [12], respectively, might play an
additive or even a synergistic role in the UVB-dependent
MMP expression. Furthermore, a complex network of Janus
kinases, mitogen-activated and stress-activated protein kinases
are discussed to be dependent on IL-6 and to support MMP
induction [12,43,44].
In conclusion, the novel ¢nding of this study is that UVB
irradiation of human dermal ¢broblasts resulted in the syn-
thesis and release of IL-6 which, via an autocrine mechanism,
led to the induction of MMP-1 and MMP-3, while the major
tissue inhibitor of MMPs, TIMP-1, remained almost unaf-
fected. The resulting imbalance between MMP-1/MMP-3
and TIMP-1 may lead to an enhanced connective tissue deg-
radation, a hallmark in various pathological states.
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